Grade 3 elevated ALT, AST, alkaline phosphatase, and γ-glutamyl transferase were reported for a 72-year-old male patient with colon adenocarcinoma who received BPM31510IV monotherapy at 66 mg/kg. This evidence concerns the gene GPT and colon adenocarcinoma.